Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Insight Into the UAE Experience With Monoclonal Antibodies (Sotrovimab ) as Part of Emirats Health Service (EHS)Fighting Strategy Against COVID-19.

NCT05144178 is registered in ClinicalTrials.gov with Emirates Health Services (EHS) as lead sponsor.

NCT NCT05144178
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05144178 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Insight Into the UAE Experience With Monoclonal Antibodies (Sotrovimab ) as Part of Emirats Health Service (EHS)Fighting Strategy Against COVID-19.
Lead sponsor
Emirates Health Services (EHS)
Phase
Observational
Overall status
Unknown status
Start date
November 14, 2021
Completion date
February 9, 2022
Enrollment
3,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 respiratory infection